TC-6987 for the Treatment of Mild to Moderate Asthma

NCT01296087 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: TC-6987
DRUG: Placebo

Sponsor

Targacept Inc.